110 related articles for article (PubMed ID: 8654088)
1. Serum interferon-gamma level in a patient with carbamazepine-induced erythroderma.
Koga T; Imayama S; Hori Y
Contact Dermatitis; 1995 Oct; 33(4):275. PubMed ID: 8654088
[No Abstract] [Full Text] [Related]
2. In vitro release of interferon-gamma by peripheral blood mononuclear cells of a patient with carbamazepine-induced allergic drug eruption in response to stimulation with carbamazepine.
Koga T; Imayama S; Hori Y
Contact Dermatitis; 1995 Mar; 32(3):181-2. PubMed ID: 7774202
[No Abstract] [Full Text] [Related]
3. [Erythroderma caused by carbamazepine].
Granier F; Jay P; Mauduit G; Hermier C; Thivolet J
Rev Med Interne; 1987; 8(2):206-7. PubMed ID: 2954198
[No Abstract] [Full Text] [Related]
4. [Erythroderma caused by carbamazepine. Diagnosis with skin patch].
Blasco Sarramían A; Pinilla Moraza J; Atares Pueyo MB; Lobera Labairu T; Izquier-Do Cuartero MA; San Román Lazcano FJ
An Med Interna; 1993 Jul; 10(7):341-2. PubMed ID: 8218768
[TBL] [Abstract][Full Text] [Related]
5. Unusual combination of erythroderma and agranulocytosis induced by carbamazepine.
Tayoro J; Jonville-Béra AP; Dequin PF; Autret E; Perrotin D
Therapie; 1998; 53(5):513-4. PubMed ID: 9921051
[No Abstract] [Full Text] [Related]
6. [Acute renal insufficiency, erythroderma and polyadenopathy during treatment with carbamazepine].
Chennebault JM; Dumont AM; Achard J; Alquier P; Saint-Adré JP
Therapie; 1982; 37(1):106. PubMed ID: 6211795
[No Abstract] [Full Text] [Related]
7. Erythroderma from carbamazepine.
Romaguera C; Grimalt F; Vilaplana J; Azon A
Contact Dermatitis; 1989 Apr; 20(4):304-5. PubMed ID: 2526715
[No Abstract] [Full Text] [Related]
8. [Acute renal failure and erythroderma caused by carbamazepine therapy].
Ruiz Ezquerro JJ; Arcaya Navarro J; Díaz Molina H; Sánchez Estella J; de Diego Gómez JM
An Med Interna; 1990 Apr; 7(4):216-7. PubMed ID: 2151749
[No Abstract] [Full Text] [Related]
9. [Dysimmune lymphadenopathy, erythroderma and hematologic disorders during carbamazepine treatment].
Gaulier A; Marsan C; Sigal S; Perron J; Loutre JC
Nouv Presse Med; 1980 Apr; 9(19):1388. PubMed ID: 6446081
[No Abstract] [Full Text] [Related]
10. [Erythroderma and hepatitis].
Penela Vélez de Guevara MT; Puente Sánchez MC; Jiménez Moya AI; Herrera Martín M; Romero Escós MD
An Pediatr (Barc); 2004 Oct; 61(4):353-4. PubMed ID: 15456599
[No Abstract] [Full Text] [Related]
11. Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure.
Ray-Chaudhuri K; Pye IF; Boggild M
Neurology; 1989 Mar; 39(3):436-8. PubMed ID: 2522601
[TBL] [Abstract][Full Text] [Related]
12. Exfoliative dermatitis caused by carbamazepine in a patient with isolated IgA deficiency.
Corazza M; Mantovani L; Casetta I; Virgili A
Contact Dermatitis; 1995 Dec; 33(6):447. PubMed ID: 8706421
[No Abstract] [Full Text] [Related]
13. Carbamazepine-associated exfoliative dermatitis.
Reed MD; Bertino JS; Blumer JL
Clin Pharm; 1982; 1(1):78-9. PubMed ID: 6223779
[No Abstract] [Full Text] [Related]
14. Delayed carbamazepine--induced exfoliative erythrodermia.
Blin O; Sangla I; Serratrice G
Therapie; 1991; 46(1):91. PubMed ID: 1826972
[No Abstract] [Full Text] [Related]
15. Exfoliative dermatitis due ot carbamazepine (tegretol).
Ford GR; Bieder L
N Z Med J; 1968 Dec; 68(439):386-7. PubMed ID: 4236860
[No Abstract] [Full Text] [Related]
16. [Dermatitis exfoliativa caused by carbamazepine].
Giménez García RM; Sanz Santacruz C
Rev Clin Esp; 1987 Dec; 181(9):542-3. PubMed ID: 2966420
[No Abstract] [Full Text] [Related]
17. Carbamazepine induced erythroderma with systemic lymphadenopathy.
Okuyama R; Ichinohasama R; Tagami H
J Dermatol; 1996 Jul; 23(7):489-94. PubMed ID: 8772031
[TBL] [Abstract][Full Text] [Related]
18. Extensive carbamazepine eruption with eosinophilia and pulmonary infiltrate.
Cox NH; Johnston SR; Marks J; Bates D
Postgrad Med J; 1988 Mar; 64(749):249. PubMed ID: 2971936
[No Abstract] [Full Text] [Related]
19. Warfarin-induced erythroderma.
Rowe CJ; Robertson I; James D; McMeniman E
Australas J Dermatol; 2015 Feb; 56(1):e15-7. PubMed ID: 24592901
[TBL] [Abstract][Full Text] [Related]
20. Toxic pustuloderma--a new entity?
Staughton RC; Payne CM; Harper JI; McMichen H
J R Soc Med; 1984; 77 Suppl 4(Suppl 4):6-8. PubMed ID: 6239924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
